C반응성 단백질 검사 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 어세이 유형별, 감지 범위별, 시행 환경별, 최종사용자별, 질환 영역별, 지역별 - 업계 예측(2026-2033년)

Global C-reactive Protein Testing Market size was valued at USD 3.6 Billion in 2024 and is poised to grow from USD 3.72 Billion in 2025 to USD 4.82 Billion by 2033, growing at a CAGR of 3.3% during the forecast period (2026-2033).

Advancements in nanotechnology and the development of point-of-care assays are driving significant growth in the global C-reactive protein (CRP) testing market. These innovations enhance specificity, sensitivity, and response times for on-site disease diagnosis and monitoring. Additionally, the escalating prevalence of inflammatory disorders, diabetes, and cancer is further fueling market expansion. The increasing incidence of conditions like endometriosis, alongside rising investments in the diagnostics sector and greater adoption of point-of-care devices, is expected to catalyze market growth. The key role of CRP testing as a vital diagnostic tool, particularly in early detection of various health conditions, underscores its importance in healthcare, indicating a robust demand trajectory for the global CRP testing market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-reactive Protein Testing Market Segments Analysis

Global C-reactive Protein Testing Market is segmented by Product, Assay Type, Detection Range, Setting, End User, Disease Area and region. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Assay Type, the market is segmented into Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay and Immunoturbidimetric Assay. Based on Detection Range, the market is segmented into Conventional CRP and hs-CRP. Based on Setting, the market is segmented into Laboratory Testing and Point-of-Care Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on Disease Area, the market is segmented into Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-reactive Protein Testing Market

The growth of the global C-reactive protein testing market is significantly influenced by the escalating prevalence of cardiovascular diseases and the surge in research and development efforts aimed at improving testing methodologies. As cardiovascular conditions continue to impact a substantial number of individuals, with varying degrees of severity leading to numerous fatalities, the demand for reliable diagnostic tools is intensifying. This scenario underscores the critical need for advanced C-reactive protein testing solutions, which are essential for early detection and management of inflammatory responses linked to cardiovascular health. These factors collectively contribute to the upward trajectory of the market.

Restraints in the Global C-reactive Protein Testing Market

The global C-reactive protein testing market faces several significant restraints that could hinder its growth. A prevalent lack of awareness about CRP testing, coupled with limited access to advanced technologies in various lower to medium-sized economies, is likely to impede market expansion. Furthermore, the high costs associated with testing methodologies and the substantial initial investments required for setting up the necessary infrastructure may deter potential users. These factors collectively may restrict the adoption and utilization of C-reactive protein testing solutions, ultimately affecting the overall development of the market.

Market Trends of the Global C-reactive Protein Testing Market

The Global C-reactive Protein Testing market is witnessing a significant upswing driven by a surge in awareness programs aimed at enhancing the understanding of chronic disorders and their management. Government initiatives are playing a pivotal role in promoting the importance of early diagnosis and preventative care, thereby elevating the demand for CRP testing in clinical settings. This trend is particularly pronounced in developed regions, where healthcare providers are increasingly incorporating CRP tests into routine practice. As awareness grows and healthcare systems evolve, the market is positioned for robust growth, underscoring the vital role of CRP testing in disease management and patient care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global C-reactive Protein Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Reagents & Kits
• Instruments

Global C-reactive Protein Testing Market Size by Assay Type & CAGR (2026-2033)

• Market Overview
• Chemiluminescence Immunoassay
• Enzyme-Linked Immunosorbent Assay
• Immunoturbidimetric Assay

Global C-reactive Protein Testing Market Size by Detection Range & CAGR (2026-2033)

• Market Overview
• Conventional CRP
• hs-CRP

Global C-reactive Protein Testing Market Size by Setting & CAGR (2026-2033)

• Market Overview
• Laboratory Testing
• Point-of-Care Testing

Global C-reactive Protein Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Global C-reactive Protein Testing Market Size by Disease Area & CAGR (2026-2033)

• Market Overview
• Cardiovascular Diseases
• Cancer
• Rheumatoid Arthritis
• Inflammatory Bowel Disease
• Endometriosis
• Lupus
• Others

Global C-reactive Protein Testing Market Size & CAGR (2026-2033)

• North America (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
  • US
  • Canada
• Europe (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Assay Type, Detection Range, Setting, End User, Disease Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boditech Med, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getein Biotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Bioscience Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations